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In this issue,Orans et al. (2011) andTsutakawaet al. (2011) report exciting insights into themolecular
principles governing diverse endo- and exonucleolytic cleavage specificities of members of the
RAD2/FEN superfamily of nucleases, which have critical roles in DNA replication and maintenance.The nucleases that cleave the phospho-
diester backbones of DNA and RNA
have many cellular functions, including
RNA processing and maturation, RNA
interference, apoptosis, cellular pathogen
defense, and genome replication and
maintenance. To carry out these functions,
nucleaseswith awidearrayof protein folds
have evolved diverse mechanisms for
recognizing and cleaving nucleic acids of
specific sequence (e.g., restriction endo-
nucleases), length (e.g., Dicer cleavage
of RNA), or structure (e.g., Mre11 nuclease
processing of DNA double-strand
breaks) (Yang, 2011; Williams et al.,
2008). The structure-specific nucleases
include a conserved superfamily of endo-
and exonucleases whose eukaryotic
members comprise FEN1, EXO1, GEN1,
and XPG (Figure 1A). These nucleases
have critical functions, as revealed by
the fact that mutations in the genes
encoding them result in cellular stress
and genome instability and, for FEN1 and
XPG, increased cancer susceptibility
(DePamphilis, 2006; Zheng et al., 2011).
In order to avoid cell death and/or
genome instability, these nucleases
cooperate with other proteins in multistep
transactions in order to cleave their
substrates precisely and only when
needed. This raises the question of how
they find their cognate substrates, how
their substrate cleavage specificities are
determined, and how they are regulated.
Although important insights on these
issues have come from earlier structural
studies (for instance, see Chapados
et al., 2004), the underlying mechanisms
of FEN family substrate binding and
specificity have remained puzzling
because structures of the enzymes
bound to their cognate substrates havebeen lacking. Now, elegant structure-
function studies of human FEN1
(Tsutakawa et al., 2011) and EXO1 (Orans
et al., 2011) reveal a common mechanism
of DNA binding and cleavage and provide
new insights into how substrate
specificities are determined and hints as
to how the activities of these nucleases
may be regulated.
The two enzymes have distinct biolog-
ical functions. Flap endonuclease 1
(FEN1) has primary responsibility for
removing the estimated 50 million short
DNA flaps created during replication
of mammalian nuclear genomes. This
already huge workload is further in-
creased by the need to remove flaps
produced during base excision repair of
DNA lesions. EXO1 (exonuclease 1) has
several important but different functions,
including exonucleolytic digestion of
DNA during repair of potentially lethal
double-strand DNA breaks and during
repair of replication errors. Despite these
differences, the two nucleases use
a surprisingly common strategy to bind
and cleave DNA. Duplex DNA is bound
via a helix-two turn-helix (H2TH) potas-
sium-binding fold (yellow in Figure 1B)
on one side of the active site and by
additional interactions (orange) on the
other side. Using helical wedges (green)
to dramatically splay apart the DNA
duplex, both enzymes physically
segregate the 50 and 30 flanking DNA
structures. These interactions result in
a marked 90–100 DNA bend proximal
to the cleavage site and DNA 50 end
fraying of two nucleotides. This fraying
provides access to the scissile
phosphodiester bond, which is cleaved
by a common two-metal ion catalytic
mechanism (red balls, Figure 1B).CellIn addition to these common features,
differences in substrate specificity are
partly rationalized by surface pockets
unique to each enzyme that interrogate
the surrounding nucleic acid environment
(orange surfaces, Figure 1B). For EXO1,
which prefers 30 overhangs and gapped
structures, the 30 overhang is bound
via sequence nonspecific contacts to
a positively charged groove adjacent
to the active site. By comparison,
FEN1’s defining specificity for processing
Okazaki fragments bearing equilibrating
50 and 30 flaps is dictated by a 30 flap-
binding pocket that cradles the unpaired
30 end and is formed by added helical and
loop elements that are not found in Exo1.
Both EXO1 and FEN1 harbor 50 flap
endonuclease activity, and in both struc-
tures, the 50 end is directed into an active
site covered by a helical ‘‘arch’’ structure
(purple). Determinants for binding and
substrate engagement on the 50 end, in
particular 50 flap binding for FEN1
cleavage, have been a matter of debate.
Two mechanisms of flap engagement
have been proposed. One involves
tracking, in which the enzymes slide
down single-stranded DNA (ssDNA) to
engage the ssDNA/double-stranded DNA
(dsDNA) junction at a flap. The other
involves threading, in which the 50 flap is
pushed through a hole in the protein.
Based on structural observations indi-
cating that the arch helices can unfold
and in support of a threading mechanism,
Tainer and colleagues (Tsutakawa et al.,
2011) suggest that the arch collapses
with a disorder-to-order transition upon
engagement of the 50 end during
a binding and threading event. Orans
et al. (2011) suggest a third alternative
involving conformational clamping by the145, April 15, 2011 ª2011 Elsevier Inc. 171
Figure 1. Molecular Basis for FEN Family Nuclease Specificities
(A) Structures of preferred substrates for FEN family nucleases. As members of the same superfamily,
FEN1, EXO1, GEN1, and XPG are homologous, and they all cleave DNA on the 50 end of a substrate (black
arrows). However, the structures on the 50 and 30 sides of the cleavage sites vary drastically, such that
substrates can contain 50 flaps, 30 flaps, bubbles, gaps, and Holliday junctions. Gap endonuclease 1
(GEN1) participates in resolving Holliday junctions generated during recombination, and Xeroderma
pigmentosum complementation group G protein (XPG) cleaves bubble substrates arising during nucle-
otide excision repair of DNA lesions.
(B) Structural comparison of FEN1/DNA and EXO1 DNA complexes. Purple, arch region, also called the
microdomain in EXO1 or helical gateway in FEN1; yellow, H2TH DNA-binding motif; green, helical wedge;
orange, specificity binding pocket for DNA bearing either a 30 flap (FEN1) or a 30 overhang (EXO1).arch helices. The clamping model is
attractive for circumstances in which free
DNA 50 ends may not be present, such
as in bubbles and Holiday junctions.
Threading the arch in FEN1 and the
presence of its 30 flap-binding pocket
(Figure 1B) might reflect specific
mechanistic elaborations adopted by
FEN1 to convert equilibrating 50 flaps to
ligatable nicks during DNA lagging-
strand replication (Jin et al., 2001).
Deciphering flap-binding mechanism(s)
undoubtedly will involve capturing
molecular snapshots of FEN family
members bound to additional DNA
substrates, including intact, uncleaved
flaps.
Excision repair of DNA lesions requires
multiple enzymatic steps, with the product
of one enzyme serving as the substrate for
the next. Because repair ‘‘intermediates’’
canpotentiallybemore lethal ormutagenic
than the original lesion, a prevailing
hypothesis (Wilson and Kunkel, 2000) is
that coordinated ‘‘handoffs’’ occur
among repair proteins to avoid release of172 Cell 145, April 15, 2011 ª2011 Elsevier Intoxic intermediates. Nucleases can
destroy DNA and thus must be tightly
regulated. How do cells guard against
inappropriate catalysis? A great case in
point is EXO1, whose involvement in
excising replication errors requires
interaction with the mismatch recognition
complex MutSa (Genschel et al., 2002).
Beese and colleagues (Orans et al., 2011)
propose that the C terminus of EXO1 is
an autoinhibitory domain that prevents
EXO1 from excising new, correctly
replicated DNA. Inhibition is relieved
when MutSa detects a mismatch and
travels along the DNA until it encounters
EXO1 bound at a nick. When the two
proteins interact, EXO1 activation may
occur via a conformational change in the
two-helix ‘‘microdomain’’ (also known as
the arch) in EXO1 that positions the
scissile bonds over the metal center.
Thus, EXO1 is activated for mismatch
repair only when a mismatch is detected
(see Figure 6 in Orans et al., 2011).
Similarly, FEN1 binds many other
proteins and is posttranslationallyc.modified by phosphorylation, acetylation,
and methylation (Zheng et al., 2011),
potentially providing many opportunities
to regulate FEN1 activities. Deciphering
the molecular basis of these controls will
be important for understanding the roles
for FEN1 activity in multiple pathways,
including telomere maintenance,
apoptosis, replication fork rescue, and
long patch base excision repair (Zheng
et al., 2011).
As with all seminal advances, these
studies establish a testable platform for
future studies to address a number of
important questions. Do FENs thread the
arch? Precisely how do XPG and GEN1
bind substrate? Do these mechanistic
concepts extend to the FEN-related
RNA-metabolizing enzymes (XRN1 and
XRN2) (Yang, 2011)? How do protein
partnerships and covalent modifications
regulate nuclease activity? In a broader
sense, in our ever-expanding ‘‘-omics’’
world, these elegant studies are the end
products of two technical triumphs and
underscore the time-tested value of
focused, ‘‘low-throughput,’’ integrated
structure-function approaches for
understanding key cellular functions.REFERENCES
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